Tositumomab and vomiting Patient Reports February 11, 2012



Tositumomab Side Effects Report #4607790-3
Tositumomab side effect was reported by a Physician from on Mar 03, 2005. Female patient, 58 years of age, weighting 163.1 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Tositumomab. After drug was administered, patient experienced the following side effects: small intestinal obstruction, vomiting. Tositumomab dosage: unknown. During the same period patient was treated with IODINE I, IODINE I. Patient was hospitalized. Patient recovered.

Tositumomab Side Effects Report #4672424-9
Tositumomab side effect was reported by a Physician from on Mar 03, 2005. Female patient, 58 years of age, weighting 163.1 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Tositumomab. After drug was administered, patient experienced the following side effects: anaemia, lymphoma What is  lymphoma, neutropenia, pancytopenia, pyrexia, small intestinal obstruction, vomiting. Tositumomab dosage: unknown. During the same period patient was treated with IODINE I, IODINE I. Patient was hospitalized. Patient died on 05/17/2005.

Tositumomab Side Effects Report #4609557-9
Tositumomab side effect was reported by a Physician from on Feb 24, 2005. Female patient, 32 years of age, weighting 147.3 lb, was diagnosed with non-hodgkin's lymphoma, prophylaxis and was treated with Tositumomab. After drug was administered, patient experienced the following side effects: erythema, pain What is  pain, purpura, vomiting. Tositumomab dosage: unknown. During the same period patient was treated with IODINE I, IODINE I, BENADRYL, TYLENOL, CELEXA, THYROSAFE. Patient was hospitalized. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Tositumomab